Montelukast attenuates radioactive I131-induced pulmonary damage on rats

References

• Bancroft JD, Cook HC. 1994. Manual of histological techniques and their diagnostic application. Edinburgh, Scotland: Churchill Livingstone.
   Google Scholar
• Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E. 1992. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature. 360:361–364.
   PubMed Web of Science ®Google Scholar
• Charbeneau RP, Peters-golden M. 2005. Eicosanoids: mediators and therapeutic targets in fibrotic lung disease. Clin Sci. 108:479–491.
   PubMed Web of Science ®Google Scholar
• Chen L, Shen Y, Luo Q, Yu Y, Lu H, Zhu R. 2010. Pulmonary fibrosis following radioiodine therapy of pulmonary metastases from differentiated thyroid carcinoma. Thyroid. 20:337–340.
   PubMed Web of Science ®Google Scholar
• Cho SW, Choi HS, Yeom GJ, Lim JA, Moon JH, Park DJ, Chung J-K, Cho BY, Yi KH, Park YJ. 2014. Long-term prognosis of differentiated thyroid cancer with lung metastasis in korea and its prognostic factors. Thyroid. 24:277–286.
   PubMed Web of Science ®Google Scholar
• Coggle JE, Lambert BE, Moores SR. 1986. Radiation effects in the lung. Environ Health Perspect. 70:261–291.
   PubMed Web of Science ®Google Scholar
• Coskun AK, Yigiter M, Oral A, Odabasoglu F, Halici Z, Mentes O, Cadirci E, Atalay F, Suleyman H. 2011. The effects of montelukast on antioxidant enzymes and proinflammatory cytokines on the heart, liver, lungs, and kidneys in a rat model of cecal ligation and puncture-induced sepsis. TheScientificWorldJ. 11:1341–1356.
   PubMed Web of Science ®Google Scholar
• Di Maggio FM, Minafra L, Forte GI, Cammarata FP, Lio D, Messa C, Gilardi MC, Bravatà V. 2015. Portrait of inflammatory response to ionizing radiation treatment. J Inflamm. 12:14.
   Google Scholar
• Erşahin M, Çevik Ö, Akakın D, Şener A, Özbay L, Yegen BC, Şener G. 2012. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury. Prostaglandins Other Lipid Mediat. 99:131–139.
   PubMed Web of Science ®Google Scholar
• Fang SH, Yuan YM, Peng F, Li CT, Zhang LH, Lu YB, Zhang WP, Wei EQ. 2009. Pranlukast attenuates ischemia-like injury in endothelial cells via inhibiting reactive oxygen species production and nuclear factor-kappaB activation. J Cardiovasc Pharmacol. 53:77–85.
   PubMed Web of Science ®Google Scholar
• Gideroglu K, Yilmaz F, Aksoy F, Bugdayci G, Saglam I, Yimaz F. 2009. Montelukast protects axial pattern rat skin flaps against ischemia/reperfusion injury. J Surg Res. 157:181–186.
   PubMed Web of Science ®Google Scholar
• Hebestreit H, Biko J, Drozd V, Demidchik Y, Burkhardt A, Trusen A, Beer M, Reiners C. 2011. Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after chernobyl. Eur J Nucl Med Mol Imaging. 38:1683–1690.
   PubMed Web of Science ®Google Scholar
• Hung CH, Li CY, Hua YM, Chen CJ, Yang KD, Jong YJ. 2006. Effects of leukotriene receptor antagonists on monocyte chemotaxis, p38 and cytoplasmic calcium. Pediatr Allergy Immunol. 17:250–258.
   PubMed Web of Science ®Google Scholar
• Izumo T, Kondo M, Nagai A. 2007. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice. Life Sci. 80:1882–1886.
   PubMed Web of Science ®Google Scholar
• Jang EK, Kim WG, Kim H-C, Huh J-W, Kwon H, Choi YM, Jeon MJ, Kim TY, Shong YK, Ryu J-S. 2015. Changes in the pulmonary function test after radioactive iodine treatment in patients with pulmonary metastases of differentiated thyroid cancer. PLoS One. 10:e0125114.
   PubMed Web of Science ®Google Scholar
• Koca G, Gültekin SS, Han Ü, Kuru S, Demirel K, Korkmaz M. 2013. The efficacy of montelukast as a protective agent against 131I-induced salivary gland damage in rats: scintigraphic and histopathological findings. Nucl Med Commun. 34:507–517.
   PubMed Web of Science ®Google Scholar
• Koca G, Yalniz-Akkaya Z, Gültekin SS, Yumusak N, Demirel K, Korkmaz M, Atilgan HI, Altiparmak UE, Onal B, Ornek F. 2013. Radioprotective effect of montelukast sodium in rat lacrimal glands after radioiodine treatment. Revista Española De Medicina Nuclear e Imagen Molecular (English Edition). 32:294–300.
   PubMed Web of Science ®Google Scholar
• Kulkarni AA, Thatcher TH, Hsiao H-M, Olsen KC, Kottmann RM, Morrissette J, Wright TW, Phipps RP, Sime PJ. 2013. The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis. PLoS One. 8:e63798.
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. 2014. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 15:178–196.
   PubMed Web of Science ®Google Scholar
• Lee KH, Rhee KH. 2008. Radioprotective effect of cyclo(L-phenylalanyl-L-prolyl) on irradiated rat lung. J Microbiol Biotechnol. 18:369–376.
   PubMed Web of Science ®Google Scholar
• Lin Y, Bai L, Chen W, Xu S. 2010. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets. 14:45–55.
   PubMed Web of Science ®Google Scholar
• Luster M, Clarke S, Dietlein M, Lassmann M, Lind P, Oyen W, Tennvall J, Bombardieri E. 2008. Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 35:1941–1959.
   PubMed Web of Science ®Google Scholar
• Maeba S, Ichiyama T, Ueno Y, Makata H, Matsubara T, Furukawa S. 2005. Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules. Ann Allergy Asthma Immunol. 94:670–674.
   PubMed Web of Science ®Google Scholar
• Massin JP, Savoie JC, Garnier H, Guiraudon G, Leger FA, Bacourt F. 1984. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer. 53:982–992.
   PubMed Web of Science ®Google Scholar
• Reiners C, Demidchik YE, Drozd VM, Biko J. 2008. Thyroid cancer in infants and adolescents after chernobyl. Minerva Endocrinol. 33:381–395.
   PubMed Web of Science ®Google Scholar
• Scaife A, Miller D, Spiteri-Cornish D, Turner SW, Devereux GS, Walsh GM. 2013. Inhibitory effects of Montelukast on mediator release by nasal epithelial cells from asthmatic subjects with or without allergic rhinitis. Respir Med. 107:1859–1865.
   PubMed Web of Science ®Google Scholar
• Schlumberger M. 1999. Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status. J Endocrinol Invest. 22:3–7.
   PubMedGoogle Scholar
• Shaker OG, Sourour DA. 2011. Effect of leukotriene receptor antagonists on lung fibrosis in rats. J Appl Toxicol. 31:678–684.
   PubMed Web of Science ®Google Scholar
• Shimbori C, Shiota N, Okunishi H. 2011. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Eur J Pharmacol. 650:424–430.
   PubMed Web of Science ®Google Scholar
• Song H, He B, Prideaux A, Du Y, Frey E, Kasecamp W, Ladenson PW, Wahl RL, Sgouros G. 2006. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases. J Nucl Med. 47:1985–1994.
   PubMed Web of Science ®Google Scholar
• Şener G, Kabasakal L, Çetinel Ş, Contuk G, Gedik N, Yeğen BÇ. 2005. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns. 31:587–596.
   PubMed Web of Science ®Google Scholar
• Tuğtepe H, Şener G, Çetinel Ş, Velioğlu-Öğünç A, Yeğen BÇ. 2007. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. Eur J Pharmacol. 557:69–75.
   PubMed Web of Science ®Google Scholar
• Venkatesh GH, Manjunath VB, Mumbrekar KD, Negi H, Fernandes DJ, Sharan K, Banerjee S, Sadashiva SRB. 2014. Polymorphisms in radio-responsive genes and its association with acute toxicity among head and neck cancer patients. PLoS One. 9:e89079.
   PubMed Web of Science ®Google Scholar
• Vergara J, Raymond U, Thet L. 1987. Changes in lung morphology and cell number in radiation pneumonitis and fibrosis: a quantitative ultrastructural study. Int J Radiat Oncol Biol Phys. 13:723–732.
   PubMed Web of Science ®Google Scholar
• Vujaskovic Z, Groen HJ. 2000. TGF-beta, radiation-induced pulmonary injury and lung cancer. Int J Radiat Biol. 76:511–516.
   PubMed Web of Science ®Google Scholar
• Wu S, Zhu X, Jin Z, Tong X, Zhu L, Hong X, Zhu X, Liu P, Shen W. 2015. The protective role of montelukast against intestinal ischemia-reperfusion injury in rats. Sci Rep. 5:15787.
   PubMed Web of Science ®Google Scholar